“…As in previous studies, BB-12 remained viable throughout the shelf life of the product and was absent in the control product throughout the study. 11 No changes in bacterial abundance were detected for total bacteria (Eubacteria), or other beneficial bacterial species such as Bacteroides fragilis, Bifidobacterium and Lactobacillus species in fecal samples from both intervention groups after 10-day supplementation with yogurt containing B. lactis, indicating that major changes in composition of intestinal microbiota are not seen after short-term interventions with BB-12 at the current dose or may not be affected by a short term consumption of antibiotics (Table 3). Alternatively, high variability in bacterial abundance within a reduced group of subjects may have contributed to the lack of detectable change at a species level.…”